Haleon PLC
Open
SectorHealthcare
344.7 1.35
Overview
Share price change
24h
Min
340
Max
349.1
Income | 403M |
|---|---|
Sales | 2.7B |
P/E Sector Avg | 17.453 50.958 |
EPS | 0.044 |
Dividend yield | 2.13 |
Profit margin | 14.708 |
Employees | 24,535 |
EBITDA | 697M |
Recommendations | Buy |
|---|---|
12 Months Forecast | +25.71% upside |
Dividend yield Sector Avg | 2.13% 2.41% |
|---|---|
Next Earnings | 30 lip 2026 |
Next Dividend date | 17 wrz 2026 |
Next Ex Dividend date | 13 sie 2026 |
Market Cap | 29B |
|---|---|
Previous open | 343.35 |
Previous close | 344.7 |
News Sentiment
By Acuity
50%
50%
146 / 342 Ranking in Healthcare
Haleon PLC Chart
Wyniki osiągnięte w przeszłości nie są gwarantem przyszłych wyników.
About Haleon PLC
Haleon plc, together with its subsidiaries, engages in the research, development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. The company provides oral health products, such as toothpastes, mouth washes, and denture care products under the Sensodyne, Polident, Parodontax, Biotene brands; and vitamins, minerals, and supplements under Centrum, Emergen-C, Caltrate brands. It also offers various over-the-counter products comprising nasal drops, and cold, flu, and allergy relief products under Otrivine, Theraflu, and Flonase brands for respiratory issues; anti-inflammatory and pain relief products under Voltaren, Panadol, and Advil brands; and antacids and antihistamine products under TUMS, ENO, and Fenistil brands for digestive health and other issues. The company was formerly known as DRVW 2022 plc and changed its name to Haleon plc in February 2022. Haleon plc was founded in 1715 and is headquartered in Weybridge, the United Kingdom.